AnGes, Inc. (TYO:4563)
Japan · Delayed Price · Currency is JPY 48.00
0.00 (0.00%)
Jun 3, 2026, 3:30 PM JST
AnGes Market Cap
AnGes has a market cap or net worth of 19.02 billion as of June 2, 2026. Its market cap has decreased by -24.94% in one year.
Market Cap
19.02B
Enterprise Value
18.88B
Revenue
908.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
48.00
Market Cap Chart
Since September 25, 2002, AnGes's market cap has decreased from 23.36B to 19.02B, a decrease of -18.56%. That is a compound annual growth rate of -0.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 19.02B | -19.53% |
| Dec 30, 2025 | 23.64B | 57.68% |
| Dec 30, 2024 | 14.99B | 5.37% |
| Dec 29, 2023 | 14.23B | -31.96% |
| Dec 30, 2022 | 20.91B | -64.42% |
| Dec 30, 2021 | 58.78B | -64.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cuorips | 40.92B |
| Japan Tissue Engineering | 24.69B |
| Renascience | 18.25B |
| StemRIM | 17.93B |
| RaQualia Pharma | 13.04B |
| ReproCELL | 12.26B |
| Stella Pharma | 11.88B |
| CanBas | 11.33B |